Moderna, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Moderna, Inc. is a pharmaceutical and biotechnology company that uses mRNA science to create medicines and vaccines that help the immune system protect against disease. It is well-known for its recent vaccine against COVID-19. Moderna also researches ways to protect people from other infectious diseases, cancer, autoimmune diseases, and more.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Moderna, Inc. is responsible for positive Humankind Value. This outcome is largely driven by Healthcare R&D ($68.7 B), Pharmaceuticals ($11.0 B), and Economic Value ($1.6 B). Healthcare is a central component of our measure of Humankind Value, as a large contribution to modern life expectancies has come from the last 150 years of medical innovation. The company produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. Positive value from Healthcare R&D and Pharmaceuticals contains our estimation of 1,655,063.5 additional years lived by people worldwide. However, there is room for improvement with respect to Greenhouse Gases (-$286.9 M) and Air Pollution (-$57.8 M). Healthcare R&D, Pharmaceuticals, Economic Value, Greenhouse Gases, and Air Pollution are attached to this company as a result of its direct business activities.